5 Best Low Price Stocks To Own For 2014

Bed Bath & Beyond Inc. (NASDAQ:BBBY) is expected to report its second quarter financial results on�Sept.25. The company will hold a conference call at�5.00pm�eastern time on the same day to discuss the results.

With 1,400 plus stores, Bed Bath & Beyond operates a chain of home-decor retailer under the names Bed Bath & Beyond in the United States and Canada, as well as, World Market, Cost Plus World Market, Christmas Tree Shops, and That!, Harmon, Harmon Face Values and buybuy BABY in the United States.

The quarterly results could help investors to gauge how well the improvement in the housing market is helping the company, which sells all sorts of housewares, home furnishings and bath items at everyday low prices.

In the quarterly results, investors could look for answers to questions such as the threat from online competition, an uncertain margin outlook, and the waning contribution from product trends like single-serve coffee.

Hot US Companies To Invest In Right Now: Idera Pharmaceuticals Inc.(IDRA)

Idera Pharmaceuticals, Inc., a biotechnology company, discovers and develops DNA- and RNA-based drug candidates for the treatment of infectious diseases, autoimmune and inflammatory diseases, cancer, and asthma and allergies, and for use as vaccine adjuvants. The company designs and creates proprietary Toll-Like Receptors (TLR) to modulate immune responses, including TLR agonist, a compound that stimulates an immune response through the targeted TLR; and TLR antagonist, a compound that blocks activation of an immune response through the targeted TLR. Its drug candidates include IMO-2125, a TLR9 agonist, which is in Phase 1 clinical trial for hepatitis C virus infection; and TLR7, 8, and 9 agonists that are in research stage for viral diseases. The company also develops IMO-3100, a dual TLR7/TLR9 antagonist, which is in preclinical development stage for autoimmune and inflammatory diseases, such as lupus, rheumatoid arthritis, multiple sclerosis, psoriasis, and colitis. In addition, its drug candidates also comprise TLR7 and TLR8 agonists that are in research stage for solid tumor cancers. The company has a licensing and collaboration agreement with Merck KGaA to research, develop, and commercialize TLR9 agonists for the treatment of cancer, excluding cancer vaccines; a license and research collaboration agreement with Merck & Co., Inc. to research, develop, and commercialize therapeutic and prophylactic vaccine products containing its TLR7, 8, and 9 agonists in the fields of cancer, infectious diseases, and Alzheimer?s disease; and a research collaboration and option agreement, and a license, development, and commercialization agreement with Novartis International Pharmaceutical, Ltd. to discover, develop, and commercialize TLR9 agonists for the treatment of asthma and allergies. The company was founded in 1989 and is based in Cambridge, Massachusetts.

Advisors' Opinion:

• [By Jake L'Ecuyer]

  Leading and Lagging Sectors
  In trading on Tuesday, healthcare shares were relative leaders, up on the day by about 1.50 percent. Meanwhile, top gainers in the sector included Allergan (NYSE: AGN), up 15.7 percent, and Idera Pharmaceuticals (NASDAQ: IDRA), up 16.5 percent. Non-cyclical consumer goods & services shares dropped around 0.05 percent in today's trading.

• [By John Udovich]

  Yesterday, small cap�biotech Idera Pharmaceuticals Inc (NASDAQ: IDRA) surged 21.89% apparently on news about open enrollment for a clinical trial in what amounts to an orphan drug treatment, meaning its probably worth taking a closer look at the stock as well as consider its performance verses that of biotech ETFs like the iShares NASDAQ Biotechnology Index ETF (NASDAQ: IBB) and SPDR S&P Biotech ETF (NYSEARCA: XBI).

• [By Monica Gerson]

  Idera Pharmaceuticals (NASDAQ: IDRA) is estimated to report a Q1 loss at $0.08 per share on revenue of $3.00 thousand.

  USA Technologies (NASDAQ: USAT) is projected to report its Q3 earnings at $0.00 per share on revenue of $10.63 million.

5 Best Low Price Stocks To Own For 2014: The Ultimate Software Group Inc.(ULTI)

The Ultimate Software Group, Inc., together with its subsidiaries, designs, develops, and markets unified human capital management software-as-a-service solutions to businesses in the United States and Canada. Its UltiPro software solution offers businesses with cloud-based functionality to manage the employment life cycle from recruitment to retirement. The UltiPro solution includes feature sets for talent acquisition and onboarding, human resource management and compliance, benefits management and online enrollment, payroll, performance management, salary planning and budgeting for compensation management, succession management, reporting and analytical decision-making tools, and time and attendance, as well as role-based access for executives, managers, administrators, and employees. The company offers its products and services for various industries, including manufacturing, food services, sports, technology, finance, insurance, retail, real estate, transportation, com munications, healthcare, and other services. It also provides implementation, training, maintenance, and technical support services. The Ultimate Software Group, Inc. markets its products under the UltiPro Enterprise and UltiPro Workplace brand names through its direct sales teams. The company was founded in 1990 and is headquartered in Weston, Florida.

Advisors' Opinion:

• [By Jeremy Bowman]

  What: Shares of Ultimate Software (NASDAQ: ULTI  ) were screaming "Ultimate!" today, gaining as much as 17% after topping estimates in its quarterly report.

• [By MONEYMORNING.COM]

  Jeff Bezos at Amazon.com Inc. (Nasdaq: AMZN), Steve Singh of Concur Technologies Inc. (Nasdaq: CNQR), and Scott Scherr at Ultimate Software Group Inc. (Nasdaq: ULTI) are all tied at 18 years. And Reed Hastings of Netflix Inc. (Nasdaq: NFLX) is right behind them with a 16-year stint.

• [By Patricio Kehoe]

  The firm is currently Zacks Rank # 3 - Hold, and it also has a longer-term recommendation of ��utperfom�� For investors looking for a Zacks Rank # 1 ��Strong Buy, Dealertrack Technologies Inc (TRAK), Open Text Corporation (OTEX), Pegasystems Inc. (PEGA) Solera Holdings (SLH) or Ultimate Software Group Inc. (ULTI) could be the options.

5 Best Low Price Stocks To Own For 2014: Cache Inc.(CACH)

Cache, Inc., together with its subsidiaries, operates as a mall and Web based specialty retailer of women?s lifestyle sportswear and dresses in the United States. It offers eveningwear; casual and daytime sportswear, including tops, bottoms, and dresses; and accessories, such as jewelry, belts, and handbags under the Cache brand name. The company also provides its products online through its Web site, cache.com. As of March 22, 2012, it operated 267 stores in 43 states, Puerto Rico, and the U.S. Virgin Islands. Cache, Inc. was founded in 1975 and is headquartered in New York, New York.

Advisors' Opinion:

• [By John Udovich]

  As we head into Black Friday and the holiday shopping season, small cap apparel retail stocks Cache, Inc (NASDAQ: CACH), Stein Mart, Inc (NASDAQ: SMRT), Pacific Sunwear of California, Inc (NASDAQ: PSUN) and Destination XL Group Inc (NASDAQ: DXLG) have the distinction of being the best performing small cap apparel retail stocks for this year (according to Finviz.com) with gains of 111.6%, 92.7%, 88.7% and 65.7%, respectively. What are these high flying small caps doing right in the apparel retail space and will they continue delivering a stellar performance for Black Friday and the all important holiday season for�investors? Here is what new and existing investors and traders alike need to know or consider:

5 Best Low Price Stocks To Own For 2014: iShares Morningstar Small-Cap Value ETF (JKL)

iShares Morningstar Small Value Index Fund (the Fund) seeks investment results that correspond generally to the price and yield performance of the Morningstar Small Value Index (the Index). The Index measures the performance of stocks issued by small-capitalization companies that have exhibited value characteristics as determined by Morningstar, Inc.'s (Morningstar) index methodology. Index constituents are drawn from the pool of liquid, United States-domiciled stocks that trade publicly on the NYSE, the AMEX or NASDAQ.

The Morningstar index methodology defines small-capitalization stocks as those stocks that form the 7% of market capitalization between the 90th and 97th percentile of the market capitalization of the stocks eligible to be included in the Morningstar US Market Index (a market index that represents approximately 97% of the market capitalization of publicly traded United States stocks). The Fund uses a representative sampling strategy in seeking to track the Index.

Advisors' Opinion:

• [By Todd Shriber, ETF Professor]

  Unusual volume (at least 5X ADV): QuantShares US Market Neutral Anti-Beta ETF (NYSE: BTAL), iShares 10+ Year Credit Bond ETF (NYSE: CLY), iShares Morningstar Small Value ETF (NYSE: JKL) and the PowerShares Dynamic Energy ETF (NYSE: PXI).